Verification of the fetal valproate syndrome phenotype.
Ardinger HH, Atkin JF, Blackston RD, Elsas LJ, Clarren SK, Livingstone S, Flannery DB, Pellock JM, Harrod MJ, Lammer EJ, et al.
Ardinger HH, et al.
Am J Med Genet. 1988 Jan;29(1):171-85. doi: 10.1002/ajmg.1320290123.
Am J Med Genet. 1988.
PMID: 3125743
Review.
We have evaluated 19 children who were exposed to valproic acid (VPA) in utero to look for manifestations of a fetal valproate syndrome (FVS), as proposed by Di Liberti et al. [1984]. We found no consistent alterations of pre- or postnatal growth with exposure to VPA monot …
We have evaluated 19 children who were exposed to valproic acid (VPA) in utero to look for manifestations of a fetal valproate syndrome …